Accession Number: | 0001493152-23-001919 |
Date: | 2023-01-17 |
Issuer: | VYANT BIO, INC. (VYNT) |
Original Submission Date: |
FLETCHER R JOHN
C/O VYANT BIO, INC.
2370 STATE ROUTE 70, SUITE 310
CHERRY HILL,, NJ 08002
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.0001 PAR VALUE | 2023-01-17 | A | 4,368 | a | $0.00 | 23,895 | direct | ||
COMMON STOCK, $0.0001 PAR VALUE | 2023-01-17 | 0 | $0.00 | 6,060 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | on january 17, 2023, the reporting person was granted 4,368 restricted stock units, which will be settled in shares of common stock, par value $0.0001. the restricted stock units fully vest on january 17, 2024, so long as reporting person remains a director through that date. |